Telix Shares Drop as SEC Probes Disclosures Tied to Prostate Cancer Drug Pipeline

bloomberg.com/news/articles/2025-07-23/telix-pharmaceuticals-hit-by-sec-subpoena-over-prostate-cancer-drug-disclosures

This story appeared on bloomberg.com, 2025-07-23 02:48:11.054000.
The Entire Business World on a Single Page. Free to Use →